The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial
Open accessAbstract
BACKGROUND Eosinophilic inflammation has been implicated in the pathogenesis, severity, and treatment responsiveness of chronic rhinosinusitis with nasal polyps (CRSwNP). OBJECTIVE We sought to assess the efficacy and safety of benralizumab-mediated eosinophil depletion for treating CRSwNP. METHODS The phase 3 OSTRO study enrolled patients with severe CRSwNP who were symptomatic despite treatment with intranasal corticosteroids and who had a history of systemic corticosteroid (SCS) use and/or surgery for nasal polyps (NP). Patients were randomized 1:1 to treatment with benralizumab 30 mg or placebo every 4 weeks for the first 3 doses and every 8 weeks thereafter. Co-primary endpoints were change from baseline to week 40 in nasal polyp score (NPS) and patient-reported biweekly mean nasal blockage score (NBS). RESULTS The study population comprised 413 randomized patients (benralizumab, 207; placebo, 206). Benralizumab significantly improved NPS and NBS compared with placebo at week 40 (P ≤ .005). Improvements in Sinonasal Outcome Test-22 score at week 40, time to first NP surgery and/or SCS use for NP, and time to first NP surgery were not statistically significant between treatment groups. Nominal significance was achieved for improvement in difficulty in sense of smell score at week 40 (P = .003). Subgroup analyses suggested influences of comorbid asthma, number of NP surgeries, sex, body mass index, and baseline blood eosinophil count on treatment effects. Benralizumab was safe and well tolerated. CONCLUSION Benralizumab added to standard-of-care therapy reduced NPS, decreased nasal blockage, and reduced difficulty with sense of smell compared with placebo in patients with CRSwNP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
European Position Paper on Rhinosinusitis and Nasal Polyps 2020
Fokkens, W. J., Lund, V. J., Hopkins, C., Hellings, P. W., Kern, R., Reitsma, S., Toppila-Salmi, S., Bernal-Sprekelsen, M., Mullol, J., Alobid, I., et al. (2020) · Rhinology journal · doi:10.4193/rhin20.600 · Cited by 5,882
Self-citationDoty, R. L., Shaman, P., & Dann, M. (1984) · Physiology & Behavior · doi:10.1016/0031-9384(84)90269-5 · Cited by 1,854
Psychometric validity of the 22‐item Sinonasal Outcome Test
Hopkins, C., Gillett, S., Slack, R., Lund, V. J., & Browne, J. P. (2009) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2009.01995.x · Cited by 1,621
Self-citationInternational consensus statement on allergy and rhinology: rhinosinusitis 2021
Orlandi, R. R., Kingdom, T. T., Smith, T. L., Bleier, B., DeConde, A., Luong, A. U., Poetker, D. M., Soler, Z., Welch, K. C., Wise, S. K., et al. (2021) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22741 · Cited by 959
Self-citationJuniper, E. F., Svensson, K., Mörk, A.-C., & Ståhl, E. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2004.10.008 · Cited by 929
Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study
Tokunaga, T., Sakashita, M., Haruna, T., Asaka, D., Takeno, S., Ikeda, H., Nakayama, T., Seki, N., Ito, S., Murata, J., et al. (2015) · Allergy · doi:10.1111/all.12644 · Cited by 710
Han, J. K., Bachert, C., Fokkens, W., Desrosiers, M., Wagenmann, M., Lee, S. E., Smith, S. G., Martin, N., Mayer, B., Yancey, S. W., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00097-7 · Cited by 628
Self-citationWang, X., Zhang, N., Bo, M., Holtappels, G., Zheng, M., Lou, H., Wang, H., Zhang, L., & Bachert, C. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.05.041 · Cited by 616
Self-citationKolbeck, R., Kozhich, A., Koike, M., Peng, L., Andersson, C. K., Damschroder, M. M., Reed, J. L., Woods, R., Dall'Acqua, W. W., Stephens, G. L., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.04.004 · Cited by 586
Chronic Rhinosinusitis with Nasal Polyps
Stevens, W. W., Schleimer, R. P., & Kern, R. C. (2016) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2016.04.012 · Cited by 571
The Lund‐Mackay staging system for chronic rhinosinusitis: How is it used and what does it predict?
Hopkins, C., Browne, J. P., Slack, R., Lund, V., & Brown, P. (2007) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2007.02.004 · Cited by 553
Self-citationImmunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis
Schleimer, R. P. (2017) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100401 · Cited by 546
Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic Rhinosinusitis
Stevens, W. W., Peters, A. T., Tan, B. K., Klingler, A. I., Poposki, J. A., Hulse, K. E., Grammer, L. C., Welch, K. C., Smith, S. S., Conley, D. B., et al. (2019) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2019.05.009 · Cited by 457
Bachert, C., Han, J. K., Wagenmann, M., Hosemann, W., Lee, S. E., Backer, V., Mullol, J., Gevaert, P., Klimek, L., Prokopakis, E., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.11.013 · Cited by 355
Self-citationBachert, C., Marple, B., Schlosser, R. J., Hopkins, C., Schleimer, R. P., Lambrecht, B. N., Bröker, B. M., Laidlaw, T., & Song, W.-J. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00218-1 · Cited by 327
Self-citationCluster Analysis of Obesity and Asthma Phenotypes
Sutherland, E. R., Goleva, E., King, T. S., Lehman, E., Stevens, A. D., Jackson, L. P., Stream, A. R., Fahy, J. V., & Donald Y. M. Leung2, 4. F. T. A. C. R. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036631 · Cited by 216
Molecular and Cellular Staging for the Severity of Chronic Rhinosinusitis
Kountakis, S. E., Arango, P., Bradley, D., Wade, Z. K., & Borish, L. (2004) · The Laryngoscope · doi:10.1097/01.mlg.0000147917.43615.c0 · Cited by 210
Calus, L., Van Bruaene, N., Bosteels, C., Dejonckheere, S., Van Zele, T., Holtappels, G., Bachert, C., & Gevaert, P. (2019) · Clinical and Translational Allergy · doi:10.1186/s13601-019-0269-4 · Cited by 210
Self-citationVlaminck, S., Vauterin, T., Hellings, P. W., Jorissen, M., Acke, F., Van Cauwenberge, P., Bachert, C., & Gevaert, P. (2014) · American Journal of Rhinology & Allergy · doi:10.2500/ajra.2014.28.4024 · Cited by 205
Self-citationReductions in eosinophil biomarkers by benralizumab in patients with asthma
Pham, T.-H., Damera, G., Newbold, P., & Ranade, K. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.01.003 · Cited by 185
Harrison, T. W., Chanez, P., Menzella, F., Canonica, G. W., Louis, R., Cosio, B. G., Lugogo, N. L., Mohan, A., Burden, A., McDermott, L., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30414-8 · Cited by 175
van der Veen, J., Seys, S. F., Timmermans, M., Levie, P., Jorissen, M., Fokkens, W. J., & Hellings, P. W. (2017) · Allergy · doi:10.1111/all.12983 · Cited by 172
Chen, S., Zhou, A., Emmanuel, B., Thomas, K. S., & Guiang, H. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1815682 · Cited by 142
Endotypes of chronic rhinosinusitis: Impact on management
Cardell, L., Stjärne, P., Jonstam, K., & Bachert, C. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.01.019 · Cited by 104
Self-citationObesity increases the prevalence and the incidence of asthma and worsens asthma severity
Barros, R., Moreira, P. A. M., Padrão, P., Teixeira, V. H., Carvalho, P., Delgado, L., & Moreira, A. M. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.06.023 · Cited by 103
Staikūnienė, J., Vaitkus, S., Japertienė, L. M., & Ryškienė, S. (2008) · Medicina · doi:10.3390/medicina44040033 · Cited by 102
Tversky, J. R., Lane, A. P., & Azar, A. (2021) · Clinical & Experimental Allergy · doi:10.1111/cea.13852 · Cited by 99
Self-citationDexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size
Laidlaw, T., Prussin, C., Panettieri, R., Lee, S. E., Ferguson, B., Adappa, N., Lane, A., Palumbo, M. L., Sullivan, M., Archibald, D., et al. (2018) · The Laryngoscope · doi:10.1002/lary.27564 · Cited by 95
Bachert, C., Marple, B., Hosemann, W., Cavaliere, C., Wen, W., & Zhang, N. (2020) · Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2020.03.007 · Cited by 93
Self-citationWang, M., Bu, X., Luan, G., Lin, L., Wang, Y., Jin, J., Zhang, L., & Wang, C. (2020) · Clinical and Translational Allergy · doi:10.1186/s13601-020-00332-z · Cited by 74
Lombardo, N., Pelaia, C., Ciriolo, M., Corte, M. D., Piazzetta, G. L., Lobello, N., Viola, P., & Pelaia, G. (2020) · International Journal of Immunopathology and Pharmacology · doi:10.1177/2058738420950851 · Cited by 66
Zuo, K., Guo, J., Chen, F., Xu, R., Xu, G., Shi, J., & Li, H. (2014) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-014-2910-0 · Cited by 65
T-cell phenotypes in chronic rhinosinusitis with nasal polyps in Japanese patients
Baba, S., Kagoya, R., Kondo, K., Suzukawa, M., Ohta, K., & Yamasoba, T. (2015) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-015-0100-2 · Cited by 57
Chitguppi, C., Patel, P. N., Gandler, A., Murphy, K. A., Khoury, T., Monostra, P., Bork, S., Toskala, E. M., Rabinowitz, M., Rosen, M. R., et al. (2020) · American Journal of Rhinology and Allergy · doi:10.1177/1945892420978351 · Cited by 24
Cited by
Neuroimmune mechanisms of type 2 inflammation in the skin and lung
Tamari, M., & Ver Heul, A. M. (2025) · Allergology International · doi:10.1016/j.alit.2025.02.001 · Cited by 17
Metadata
- Authors
- Bachert, C., Han, J. K., Desrosiers, M. Y., Gevaert, P., Heffler, E., Hopkins, C., Tversky, J. R., Barker, P., Cohen, D., Emson, C., Martin, U. J., Shih, V. H., Necander, S., Kreindler, J. L., Jison, M., & Werkström, V.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2022-04
- Volume
- 149
- Issue
- 4
- Pages
- 1309-1317.e12
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W3203577554
- Cited by
- 336
- References
- 34
- FWCI
- 39.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.